Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenofibrate versus clofibrate for term neonates with hyperbilirubinemia
IRCT20190708044158N1Phase 3Completed
- Sponsor
- Babol University of Medical Sciences
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in jaundice and hyperbilirubinemia comparing Fenofibrate group with Clofibrate group (2 arms). Primary endpoint: Serum bilirubin level. Started Nov 2019; status: completed.
02
Drugs
fenofibrateclofibride
03
Conditions
jaundicehyperbilirubinemia
Beyond the preview
Go deeper on IRCT20190708044158N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190708044158N1.